Safety of Administering Live Vaccines During Pregnancy: A Systematic Review and Meta-Analysis of Pregnancy Outcomes.

live attenuated vaccines pregnancy outcomes pregnant women safety

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
11 Mar 2020
Historique:
received: 25 01 2020
revised: 13 02 2020
accepted: 15 02 2020
entrez: 15 3 2020
pubmed: 15 3 2020
medline: 15 3 2020
Statut: epublish

Résumé

Live-attenuated vaccines (LAV) are currently contraindicated during pregnancy, given uncertain safety records for the mother-infant pair. LAV might, however, play an important role to protect them against serious emerging diseases, such as Ebola and Lassa fever. For this systematic review we searched relevant databases to identify studies published up to November 2019. Controlled observational studies reporting pregnancy outcomes after maternal immunization with LAV were included. The ROBINS-I tool was used to assess risk of bias. Pooled odds ratios (OR) were obtained under a random-effects model. Of 2831 studies identified, fifteen fulfilled inclusion criteria. Smallpox, rubella, poliovirus, yellow fever and dengue vaccines were assessed in these studies. No association was found between vaccination and miscarriage (OR 0.98, 95% CI 0.87-1.10), stillbirth (OR 1.04, 95% CI 0.74-1.48), malformations (OR 1.09, 95% CI 0.98-1.21), prematurity (OR 0.99, 95% CI 0.90-1.08) or neonatal death (OR 1.06, 95% CI 0.68-1.65) overall. However, increased odds of malformations (OR 1.24; 95% CI 1.03-1.49) and miscarriage after first trimester immunization (OR 4.82; 95% CI 2.38-9.77) was found for smallpox vaccine. Thus, we did not find evidence of harm related to LAV other than smallpox with regards to pregnancy outcomes, but quality of evidence was very low. Overall risks appear to be small and have to be balanced against potential benefits for the mother-infant pair.

Identifiants

pubmed: 32168941
pii: vaccines8010124
doi: 10.3390/vaccines8010124
pmc: PMC7157743
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Calif Med. 1969 Mar;110(3):224-7
pubmed: 5773481
Turk J Pediatr. 2012 May-Jun;54(3):230-3
pubmed: 23094531
JAMA. 1981 Sep 25;246(13):1413-7
pubmed: 7265443
Birth Defects Res A Clin Mol Teratol. 2008 Jul;82(7):533-9
pubmed: 18496830
J Obstet Gynaecol Br Commonw. 1964 Feb;71:132-4
pubmed: 14117229
Pediatrics. 1949 Apr;3(4):456-67
pubmed: 18118946
Public Health Rep. 1949 Mar 11;64(10):319-23
pubmed: 18114607
Indian J Med Res. 2008 Jun;127(6):551-4
pubmed: 18765873
J Infect Dis. 2017 Oct 17;216(7):834-841
pubmed: 28968794
Aust N Z J Obstet Gynaecol. 1973 May;13(2):72-6
pubmed: 4518718
J Med Virol. 2000 May;61(1):155-8
pubmed: 10745249
J Infect Dis. 2011 Sep 1;204 Suppl 2:S713-7
pubmed: 21954271
J Infect Dis. 2011 Sep 1;204 Suppl 2:S745-7
pubmed: 21954276
S Afr Med J. 1957 Jan 5;31(1):1-3
pubmed: 13391110
Trop Med Int Health. 2007 Jul;12(7):833-7
pubmed: 17596249
J Infect Dis. 2011 Sep 1;204 Suppl 2:S737-44
pubmed: 21954275
Vaccine. 2015 Oct 26;33(43):5822-5828
pubmed: 26409139
N Engl J Med. 1971 Apr 15;284(15):870-3
pubmed: 5549828
Trop Med Int Health. 1998 Jan;3(1):29-33
pubmed: 9484965
Reprod Toxicol. 2008 Jan;25(1):120-3
pubmed: 17977696
Rev Infect Dis. 1985 Mar-Apr;7 Suppl 1:S95-102
pubmed: 4001743
J Clin Pathol. 1966 Jul;19(4):328-30
pubmed: 5951719
Immunohorizons. 2018 Jan 1;2(1):14-25
pubmed: 29457151
Indian J Pediatr. 2009 Mar;76(3):279-82
pubmed: 19347667
Am J Med Genet A. 2004 Sep 15;130A(1):52-4
pubmed: 15368496
Am J Obstet Gynecol. 1973 Oct 15;117(4):505-12
pubmed: 4743357
Vaccine. 2018 May 31;36(23):3345-3350
pubmed: 29716774
Vaccine. 2017 Dec 4;35(48 Pt A):6575-6581
pubmed: 28479177
JAMA. 1973 Sep 17;225(12):1472-6
pubmed: 4740718
Vaccine. 1999 Jan 21;17(3):283-5
pubmed: 9987164
Am J Obstet Gynecol. 1963 Jan 15;85:238-40
pubmed: 13961615
S Afr Med J. 1959 Apr 25;33(17):357-8
pubmed: 13659139
Br Med J. 1964 Jun 13;1(5397):1544-6
pubmed: 14133608
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Trans R Soc Trop Med Hyg. 1993 May-Jun;87(3):337-9
pubmed: 8236412
Am J Perinatol. 2016 Sep;33(11):1104-14
pubmed: 27603545
Vaccine. 2014 Dec 12;32(52):7057-64
pubmed: 25285883
Clin Vaccine Immunol. 2010 Jan;17(1):118-26
pubmed: 19906894
Lancet. 1990 Mar 31;335(8692):800
pubmed: 1969549
Rev Infect Dis. 1985 Mar-Apr;7 Suppl 1:S103-7
pubmed: 4001718
JAMA. 1974 Feb 11;227(6):621-7
pubmed: 4405819
Acta Obstet Gynecol Scand. 1995 Apr;74(4):262-5
pubmed: 7732798
Pediatr Infect Dis J. 2007 Sep;26(9):830-5
pubmed: 17721380
Vaccine. 2019 May 3;:
pubmed: 31060949
Obstet Gynecol. 1975 Aug;46(2):223-6
pubmed: 1153153
J Infect Dis. 1993 Dec;168(6):1520-3
pubmed: 8245539
Obstet Gynecol. 1985 Jul;66(1):121-3
pubmed: 4011062
Hum Vaccin Immunother. 2016 Apr 2;12(4):848-56
pubmed: 26857450
Emerg Infect Dis. 2019 Aug;25(8):
pubmed: 31310586
Am J Epidemiol. 1993 Sep 15;138(6):407-14
pubmed: 8213746
CDR (Lond Engl Rev). 1991 Jul 19;1(8):R86-8
pubmed: 1669784
Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S221-6
pubmed: 18284362
Lancet. 1952 Dec 6;2(6745):1104-6
pubmed: 12991732
J R Coll Gen Pract. 1984 Jul;34(264):390-4
pubmed: 6747944
Vaccine. 2006 Feb 27;24(9):1421-6
pubmed: 16236402
Br Med J (Clin Res Ed). 1986 Mar 15;292(6522):727
pubmed: 3082412
MMWR Morb Mortal Wkly Rep. 2014 Aug 22;63(33):732-3
pubmed: 25144545
Obstet Gynecol. 1971 Oct;38(4):641-2
pubmed: 5098493
N Engl J Med. 1976 Apr 29;294(18):972-4
pubmed: 943697
Clin Infect Dis. 1994 Mar;18(3):414-20
pubmed: 8011825
J Infect Dis. 2011 Sep 1;204 Suppl 2:S722-8
pubmed: 21954273
MMWR Morb Mortal Wkly Rep. 2008 Jan 11;57(1):1-5
pubmed: 18185492
J Infect Dis. 2011 Sep 1;204 Suppl 2:S729-36
pubmed: 21954274
Clin Infect Dis. 2016 Dec 1;63(suppl 4):S236-S243
pubmed: 27838678
Vaccine. 2015 Nov 25;33(47):6469-72
pubmed: 26256526
Vaccine. 2006 Apr 24;24(17):3558-63
pubmed: 16510217
Lancet. 1993 May 1;341(8853):1162
pubmed: 8097854
Am J Public Health Nations Health. 1968 Oct;58(10):1910-21
pubmed: 5693017

Auteurs

Almudena Laris-González (A)

Hospital Infantil de México Federico Gómez, Mexico 06720, Mexico.
London School of Hygiene and Tropical Medicine (Alumni), London WC1E 7HT, UK.

Daniel Bernal-Serrano (D)

London School of Hygiene and Tropical Medicine (Alumni), London WC1E 7HT, UK.
Compañeros en Salud-Partners in Health México, Mexico 11800, Mexico.
Instituto Tecnológico y de Estudios Superiores de Monterrey, Mexico 14380, Mexico.

Alexander Jarde (A)

Disease Control Elimination Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, P.O. Box 273, Banjul, Gambia.

Beate Kampmann (B)

The Vaccine Centre, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Vaccines & Immunity Theme, MRC Unit the Gambia at the London School of Hygiene and Tropical Medicine, P.O. Box 273, Banjul, Gambia.

Classifications MeSH